Press Releases - NEWS - Laekna

NEWS

PRESS CENTER

*All pictures are taken at Laekna offices

Scroll down to see more

Latest Articles

Media Coverage Press Releases

Search

2022-01-07

Laekna Therapeutics and Innovent Biologics obtain IND approval for combination therapy in patients with specific types of solid tumors who have been refractory to treatment with PD-1/PD-L1 inhibitors

Laekna Therapeutics and Innovent Biologics obtain IND approval for combination therapy in patients with specific types of solid tumors who have been refractory to treatment with PD-1/PD-L1 inhibitors
More

More

More
2021-12-23

Laekna Presents Vision and Strategy at NewYorkBIO/NYSE Emerging Company Showcase
More
2021-10-19

Laekna hits the headlines during Shanghai International Biopharma Industry Week 2021
More
2021-09-16

Laekna Therapeutics reported positive results in two clinical studies for the treatment of various stages of prostate cancer at the ESMO Congress
More
2021-08-26

Laekna Therapeutics receives IND approvals in China and US for phase Ib/III global multi-center clinical study of afuresertib in combination with fulvestrant for patients with hr+/her2- breast cancer
More
2021-07-26

Laekna Therapeutics will present two clinical study results in ESMO 2021
More
2021-07-05

Laekna Therapeutics and Innovent enter a partnership agreement to co-develop combination therapy of afuresertib and sintilimab in clinical studies in China
More

<1 3 4 5 6 7 8 >

Media contact

communication@laekna.com

RSS Feeds

If you want to know more about Laekna, please fill in the form below and sign up for emails:

Follow us on Linkedin